Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 21;28(4):576-585.
doi: 10.5606/tgkdc.dergisi.2020.19768. eCollection 2020 Oct.

Association between the low percentage of forced vital capacity and increased mortality after left ventricular assist device implantation

Pervin Korkmaz Ekren  1 , Pelin Öztürk  2 , Serkan Ertugay  2 , Ali Özdil  3 , Sanem Nalbantgil  4 , Çağatay Engin  2 , Tahir Yağdı  2 , Mustafa Özbaran  2
Affiliations

Association between the low percentage of forced vital capacity and increased mortality after left ventricular assist device implantation

Pervin Korkmaz Ekren et al. Turk Gogus Kalp Damar Cerrahisi Derg. .

Abstract

Background: This study aims to investigate the effect of low percentage of forced vital capacity measured in the preoperative period on the 28-day mortality in patients undergoing left ventricular assist device implantation.

Methods: A total of 131 patients (111 males, 20 females; median age 54 years; range, 47 to 59 years) who underwent left ventricular assist device implantation with HeartWare™ between December 2010 and January 2016 were retrospectively analyzed. The patients were divided into two groups according to the results of pulmonary function test as a forced vital capacity percentage of ≥60% (n=113) and <60% (n=18). Both groups were compared in terms of laboratory and clinical characteristics, and postoperative complications. Risk factors for postoperative 28-day mortality were analyzed.

Results: Pre- and intraoperative characteristics were similar in both groups, except for left ventricular end-diastolic diameter. The ventilator-free days up to 28 days was shorter (p=0.046) and the length of intensive care unit stay was longer (p=0.011) in the low percentage of forced vital capacity group. The 28-day mortality rate was also higher (22.2% vs. 9.7%, respectively; p=0.12) in this group. The history of prior cardiac operation (odds ratio: 4.40; 95% confidence interval 1.19-16.20, p=0.026) and tricuspid valve repair at the time of device implantation (odds ratio: 5.30; 95% confidence interval 1.33-21.00, p=0.018) were found to be independent risk factors for mortality. Multivariate analysis showed that a forced vital capacity of <60% was not associated with mortality (odds ratio: 3.96; 95% confidence interval 0.95-16.43, p=0.058).

Conclusion: The length of intensive care unit stay and duration of mechanical ventilation may be longer in patients with a low percentage of forced vital capacity. Although the association between 28-day mortality and low percentage of forced vital capacity is not significant, the risk of 28-day mortality is higher in this group. Therefore, the patients should be assessed carefully before the left ventricular assist device operation.

Keywords: Complication; heart failure; heart-assist device; mortality; pulmonary function test.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1
Figure 1. Study flowchart.: VAD: Ventricular assist device; PFT: Pulmonary function test; ICU: Intensive care unit; FVC: Forced vital capacity.
See this image and copyright information in PMC

References

    1. Wieselthaler GM, O Driscoll G, Jansz P, Khaghani A, Strueber M, HVAD Clinical Investigators Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2010;29:1218–1225. - PubMed
    1. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505. - PubMed
    1. Birks EJ, George RS, Hedger M, Bahrami T, Wilton P, Bowles CT, et al. Reversal of severe heart failure with a continuousflow left ventricular assist device and pharmacological therapy: a prospective study. Circulation. 2011;123:381–390. - PubMed
    1. Meyer AL, Malehsa D, Bara C, Haverich A, Strueber M. Implantation of rotary blood pumps into 115 patients: a singlecentre experience. Eur J Cardiothorac Surg. 2013;43:1233–1236. - PubMed
    1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251. - PubMed

LinkOut - more resources